HPX and neoplasm: In addition, patients with Hx+-tumors had higher recurrence rate, including locoregional tumor control and distant metastases (HR: 1.387; 95% CI: 0.989–1.944, p = 0.052) than patients with tumors lacking over-expression of the hypoxia-markers (Hx−).